Our team of experienced chemists, project managers, and support staff values each client and is dedicated to moving their projects forward. We are family-owned and operated, and our small size allows us to be accessible, responsive, and to act quickly. Customers consider us for our technical expertise and outstanding history of FDA compliance, but they choose us for our engaging people found in every department from purchasing to process development.

Learn more about our team leaders below.



Louis Glunz
Louis studied chemistry at Notre Dame in the early 80s. Despite plenty of labs, Louis found time to row on the crew team, and twice competed in the Head of the Charles Regatta in Boston. Louis joined Regis in 1993 to sell chromatography products. He held some lectures with Bill Pirkle (University of Illinois) and Jorgen Hermannson (Chrom Tech). Louis also worked on customer synthesis deals and planned infrastructure expansions. He really enjoys seeing Regis add new capabilities. Louis lives in Chicago with his wife and two small children. 



Burr Martin
Burr Martin joined Regis Technologies, Inc. as Chief Financial Officer in May 2006. In this role, he was responsible for the financial operations of the company, including accounting, financial planning, treasury, and risk management. In the years following, he assumed responsibility for manufacturing and business development as Chief Operating Officer.  
Prior to Regis, Burr was Vice President of Corporate Planning & Investment Analysis at RR Donnelley, a global provider of print and print related services. Prior to RR Donnelley, Burr worked in a variety of roles for The Quaker Oats Company, with a focus on international finance and expanding Gatorade into Latin America and Asia. Earlier, he spent five years in Brussels, Belgium setting up a European Coordination Center. He began his career at The Northern Trust Company.
Burr Martin received his Master of Business Administration degree from the University of Chicago and is a graduate of Hamilton College.



Daniel Weissmueller
Dan has worked in the pharmaceutical industry for over 15 years and with Regis since 2001.  After starting in the Quality Control Department, he quickly advanced through analytical method development, validations and was promoted to his current position as Director of Quality. In the laboratory, Dan specialized in advanced analytical techniques such as HPLC, GC, and mass spectrometry. During Dan’s tenure, notable accomplishments include internal transfer of Regis’ analytical laboratories, regulatory approvals for three API products in over 30 countries and leading Regis through multiple FDA pre-approval inspections without receiving any objectionable findings (No 483s).
Dan earned his Bachelor’s Degree in Chemistry from Benedictine University and is currently pursuing his Master’s Degree in Quality and Regulatory Sciences from Northwestern University.  Prior to Regis Dan worked at Particle Technology Labs doing fine particle characterization such as include particle size, shape, porosity, pore symmetry, density, and flocculation studies. 



Marvin Palu
Marvin has worked in the pharmaceutical industry for over 10 years. He earned his Bachelor’s Degree in Chemistry from California State University—San Marcos. After graduation, he worked at Creative Nail Design Labs (now known as Revlon) doing analytical work.  Marvin relocated to Chicago in 2005 to support his wife’s medical education. 
Marvin has worked for Regis since 2005. His strong analytical skills allowed him to become an asset in the Quality Control Department and he became the QC lead in 2007. During his time as Lead, Marvin developed his managerial skills and improved the efficiency and morale of the department. After becoming the Quality Control Manager in 2013, Marvin strived and succeeded in maintaining the QC lab and personnel  to the highest industry standards. Now, as the Associate Director of Quality Control, he continues to take pride in the QC department and is excited to be part of Regis’ ongoing success.  



Andy Miles
Andy has worked in the pharmaceutical industry for 20 years and has been part of the Regis team for nearly 10 years. He started his career at Rhone Poulenc AG in Discovery Chemistry after completing his bachelor’s degree in Biological Sciences and Chemistry from East Illinois University. Andy transitioned into Business Development with Bodman Industries selling chromatography and medicinal chemistry equipment to pharmaceutical companies. He later moved on to Business Development at TharSFC (a Waters Company) focusing on Supercritical Fluid Chromatography and Extraction processes.
Since 2012 Andy’s focus has been leveraging Regis’ expertise in analytical and synthesis by starting an impurities isolation, characterization, and synthesis group for pharmaceutical companies preparing for their IND and NDA submissions.



Christine Soulje
Christine has worked in the pharmaceutical industry for over 15 years and with Regis since 2016.  She earned her Bachelor’s Degree in Chemistry from Allegheny College with honors, where she was also named an Alden Scholar and Doane Scholar. In 2000, she earned her Ph.D. in Organic Chemistry with a  Certificate in Toxicology from Duke University. 
Christine spent the majority of her career at Abbot Laboratories as a research  and analytical chemist, where she was responsible for the analytical method development and validation for drug substances, drug products, and finished dosage form dissolution/drug release and led analytical on a multi-company life cycle management development project.  At Abbvie as a senior scientist, she led several development projects in various phases of clinical development for both drug substances and drug products.  At Regis, Christine leads our team of eight analytical chemists for method development and transfer, method validation, quality control, and ICH stability studies.



Rebecca Centko
Rebecca has worked in the pharmaceutical industry for over 15 years.  She received her Bachelor’s Degree in Chemistry from the Illinois Wesleyan University. Rebecca joined Pharmacia as a medical chemist and worked in the Combinatorial Chemistry group. There, one of her main responsibilities was to design and synthesize therapeutic agents to treat CNS diseases.
Rebecca has worked for Regis as a Project Manager since 2003. She has been responsible for leading the Project Management group at Regis since 2007. In her tenure at Regis, Rebecca has managed over 100 custom manufacturing projects, ranging from pre-clinical, clinical through validation and commercial.  Rebecca and her team are the primary point of contact for the customer’s at Regis and help ensure Regis maintains focus to guarantee the customers needs are met. These needs include timelines, scope and regulatory requirements. Rebecca and the project management team are also responsible for writing the proposals at Regis.  



Siead Zegar
Siead has worked in the pharmaceutical and fine chemical industry for over 25 years. He received his Bachelor’s Degree from the University of Illinois at Chicago.  Siead began his career as an R&D chemist at Pelron Corporation and was promoted to Production Supervisor where he was responsible for overseeing R&D and production operations.  He joined deCODE, a wholly owned subsidiary of deCODE Genetics as a lab manager and advanced to Associate Director of Process Research and Development.  At deCODE Siead was responsible for overseeing the Process Research and Development group which focused on the development/optimization and scale-up of APIs. 
Siead has worked at Regis since 2009. His career with Regis began as a senior chemist in the chemical development/production group and he has recently been promoted to Manager of Process Development.  Siead oversees the Process Development group and is responsible for the development of new processes and transfer of technology to pilot plant and full scale production.



Dragan Ristic
Dragan is a chemical engineer with over 25 years of industrial experience in process development, technology transfer, and manufacturing of active pharmaceutical ingredients and specialty chemicals.  Prior to joining Regis, Dragan had worked for AstraZeneca in Europe and deCODE Genetics in the Chicago area in different engineering and scientific roles from a process engineer to a director of chemical operations.  He held leadership roles in process optimization and technology transfer from the bench to pilot plant and commercial scale focusing on product quality, practicality and safety.  He also coordinated the Pilot Plant construction, equipment installation, and start up at AstraZeneca.
Dragan is focused on expanding Regis’ capabilities in potent compound handling and processing. 



Chris Cohodes
Chris has worked in the pharmaceutical industry for 11 years. He earned his Bachelor’s Degrees in Chemical and Biomolecular Engineering and Chemisty from the University of Illinois at Urbana-Champaign and holds a Six Sigma Black Belt.
At Regis, he started as a Development Chemist and then worked as a Production Engineer. He has also worked as a Chemical Process Engineer for ITW. Throughout his tenure at Regis, he has been intimately involved in over 30 projects from process scale up to commercial scale. In 2016, he assumed the role of Plant Manager at Regis and now oversees all plant operations and personnel.



Scott Anderson
Scott has worked in the chromatography industry for over 20 years and has been with Regis since May 2016. He received his BS degree in Biochemistry from Trinity International University.  Scott leads the chromatography team at Regis which is focused on both chiral and achrial chromatography products, LC and GC reagents, and various diagnostic/imaging reagents.  
Prior to joining Regis, Scott worked at Grace/Alltech where he had a roles in product development and marketing. He developed and marketed new HPLC phases, UHPLC columns, capillary and nanobore HPLC columns, Flash Chromatography products, and Bioprocessing separations products. Scott holds 3 patents and a number of publications in the area of chromatography and is focused on adding new products to Regis’s portfolio.